1	Inhibition	Inhibition	B-NP	NN	O	9	SUB	18	Inhibition
2	of	of	B-PP	IN	O	1	NMOD	-1
3	angiogenesis	angiogenesis	B-NP	NN	O	2	PMOD	3	angiogenesis
4	by	by	B-PP	IN	O	1	NMOD	-1
5	the	the	B-NP	DT	O	8	NMOD	-1
6	cancer	cancer	I-NP	NN	O	8	NMOD	-1
7	chemopreventive	chemopreventive	I-NP	JJ	O	8	NMOD	-1
8	agent	agent	I-NP	NN	O	4	PMOD	-1
9	conjugated	conjugate	B-VP	VBD	O	0	ROOT	-1
10	linoleic	linoleic	B-NP	JJ	O	11	NMOD	-1
11	acid	acid	I-NP	NN	O	9	OBJ	-1
12	.	.	O	.	O	9	P	-1

1	Dietary	Dietary	B-NP	JJ	O	4	NMOD	-1
2	conjugated	conjugate	I-NP	VBN	O	4	NMOD	-1
3	linoleic	linoleic	I-NP	JJ	O	4	NMOD	-1
4	acid	acid	I-NP	NN	O	8	SUB	-1
5	(	(	O	(	O	7	DEP	-1
6	CLA	CLA	B-NP	NN	O	7	DEP	-1
7	)	)	O	)	O	4	NMOD	-1
8	has	have	B-VP	VBZ	O	0	ROOT	-1
9	been	be	I-VP	VBN	O	8	VC	-1
10	shown	show	I-VP	VBN	O	9	VC	-1
11	previously	previously	B-ADVP	RB	O	10	VMOD	-1
12	to	to	B-VP	TO	O	13	VMOD	-1
13	inhibit	inhibit	I-VP	VB	O	10	VMOD	0
14	rat	rat	B-NP	NN	O	16	NMOD	-1
15	mammary	mammary	I-NP	JJ	O	16	NMOD	-1
16	carcinogenesis	carcinogenesis	I-NP	NN	O	13	OBJ	0
17	.	.	O	.	O	8	P	-1

1	In	In	B-PP	IN	O	20	VMOD	-1
2	addition	addition	B-NP	NN	O	1	PMOD	0
3	to	to	B-PP	TO	O	2	NMOD	-1
4	direct	direct	B-NP	JJ	O	5	NMOD	-1
5	effects	effect	I-NP	NNS	O	3	PMOD	16	effects
6	on	on	B-PP	IN	O	5	NMOD	-1
7	mammary	mammary	B-NP	JJ	B-cell_type	9	NMOD	-1
8	epithelial	epithelial	I-NP	JJ	I-cell_type	9	NMOD	-1
9	cells	cell	I-NP	NNS	I-cell_type	6	PMOD	-1
10	,	,	O	,	O	9	P	-1
11	including	include	B-PP	VBG	O	9	NMOD	-1
12	decreased	decrease	B-NP	VBN	O	15	NMOD	18	decreased
13	proliferation	proliferation	I-NP	NN	O	15	NMOD	1	proliferation
14	and	and	I-NP	CC	O	15	NMOD	-1
15	induction	induction	I-NP	NN	O	11	PMOD	17	induction
16	of	of	B-PP	IN	O	15	NMOD	-1
17	apoptosis	apoptosis	B-NP	NN	O	16	PMOD	5	apoptosis
18	,	,	O	,	O	20	P	-1
19	CLA	CLA	B-NP	NN	O	20	SUB	-1
20	may	may	B-VP	MD	O	0	ROOT	-1
21	exert	exert	I-VP	VB	O	20	VC	-1
22	its	its	B-NP	PRP$	O	23	NMOD	-1
23	effects	effect	I-NP	NNS	O	21	OBJ	16	effects
24	indirectly	indirectly	B-ADVP	RB	O	21	VMOD	-1
25	by	by	B-PP	IN	O	21	VMOD	-1
26	inhibiting	inhibit	B-VP	VBG	O	25	PMOD	18	inhibiting
27	the	the	B-NP	DT	O	28	NMOD	-1
28	differentiation	differentiation	I-NP	NN	O	26	OBJ	2	differentiation
29	of	of	B-PP	IN	O	28	NMOD	-1
30	mammary	mammary	B-NP	JJ	B-cell_type	32	NMOD	-1
31	stromal	stromal	I-NP	JJ	I-cell_type	32	NMOD	-1
32	cells	cell	I-NP	NNS	I-cell_type	29	PMOD	-1
33	to	to	B-PP	TO	O	28	NMOD	-1
34	an	an	B-NP	DT	O	37	NMOD	-1
35	endothelial	endothelial	I-NP	JJ	O	37	NMOD	-1
36	cell	cell	I-NP	NN	O	37	NMOD	-1
37	type	type	I-NP	NN	O	33	PMOD	-1
38	.	.	O	.	O	20	P	-1

1	Specifically	Specifically	B-ADVP	RB	O	4	VMOD	-1
2	,	,	O	,	O	4	P	-1
3	CLA	CLA	B-NP	NN	B-protein	4	SUB	-1
4	was	be	B-VP	VBD	O	0	ROOT	-1
5	found	find	I-VP	VBN	O	4	VC	0
6	to	to	I-VP	TO	O	7	VMOD	-1
7	decrease	decrease	I-VP	VB	O	5	VMOD	18	decrease
8	the	the	B-NP	DT	O	9	NMOD	-1
9	ability	ability	I-NP	NN	O	7	OBJ	0
10	of	of	B-PP	IN	O	9	NMOD	-1
11	mammary	mammary	B-NP	JJ	B-cell_type	13	NMOD	-1
12	stromal	stromal	I-NP	JJ	I-cell_type	13	NMOD	-1
13	cells	cell	I-NP	NNS	I-cell_type	10	PMOD	-1
14	to	to	B-VP	TO	O	15	VMOD	-1
15	form	form	I-VP	VB	O	9	NMOD	2	form
16	complex	complex	B-NP	NN	O	15	OBJ	-1
17	anastomosing	anastomose	B-VP	VBG	O	16	NMOD	-1
18	microcapillary	microcapillary	B-NP	JJ	B-protein	19	NMOD	-1
19	networks	network	I-NP	NNS	I-protein	17	OBJ	-1
20	in	in	B-ADVP	FW	O	15	VMOD	-1
21	vitro	vitro	I-ADVP	FW	O	20	AMOD	-1
22	on	on	B-PP	IN	O	15	VMOD	-1
23	Engelbreth-Holm-Swarm-derived	Engelbreth-Holm-Swarm-derived	B-NP	JJ	O	26	NMOD	-1
24	reconstituted	reconstitute	I-NP	VBN	O	26	NMOD	0
25	basement	basement	I-NP	NN	O	26	NMOD	-1
26	membrane	membrane	I-NP	NN	O	22	PMOD	-1
27	.	.	O	.	O	4	P	-1

1	This	This	B-NP	DT	O	2	SUB	-1
2	suggested	suggest	B-VP	VBD	O	0	ROOT	-1
3	that	that	B-SBAR	IN	O	2	VMOD	-1
4	CLA	CLA	B-NP	NN	O	5	SUB	-1
5	might	might	B-VP	MD	O	3	SBAR	-1
6	inhibit	inhibit	I-VP	VB	O	5	VC	18	inhibit
7	angiogenesis	angiogenesis	B-NP	NN	O	6	OBJ	3	angiogenesis
8	in	in	B-ADVP	FW	O	6	VMOD	-1
9	vivo	vivo	I-ADVP	FW	O	8	AMOD	-1
10	.	.	O	.	O	2	P	-1

1	To	To	B-VP	TO	O	2	VMOD	-1
2	test	test	I-VP	VB	O	11	VMOD	-1
3	this	this	B-NP	DT	O	4	NMOD	-1
4	possibility	possibility	I-NP	NN	O	2	OBJ	-1
5	,	,	O	,	O	11	P	-1
6	CD2/F	CD2/F	B-NP	NN	B-protein	10	NMOD	-1
7	(	(	O	(	O	9	DEP	-1
8	1	1	B-NP	CD	O	9	DEP	-1
9	)	)	O	)	O	6	NMOD	-1
10	mice	mouse	B-NP	NNS	O	11	SUB	-1
11	were	be	B-VP	VBD	O	0	ROOT	-1
12	placed	place	I-VP	VBN	O	11	VC	19	placed
13	on	on	B-PP	IN	O	12	VMOD	-1
14	synthetic	synthetic	B-NP	JJ	O	15	NMOD	-1
15	diets	diet	I-NP	NNS	O	13	PMOD	-1
16	containing	contain	B-VP	VBG	O	15	NMOD	-1
17	0	0	B-NP	CD	O	24	NMOD	-1
18	,	,	I-NP	,	O	24	P	-1
19	1	1	I-NP	CD	O	24	NMOD	-1
20	,	,	O	,	O	24	P	-1
21	or	or	O	CC	O	24	NMOD	-1
22	2	2	B-NP	CD	O	23	AMOD	-1
23	%	%	I-NP	NN	O	24	NMOD	-1
24	CLA	CLA	I-NP	NN	O	16	OBJ	-1
25	for	for	B-PP	IN	O	24	NMOD	-1
26	6	6	B-NP	CD	O	27	NMOD	-1
27	weeks	week	I-NP	NNS	O	25	PMOD	-1
28	,	,	O	,	O	12	P	-1
29	before	before	B-PP	IN	O	12	VMOD	-1
30	angiogenic	angiogenic	B-NP	JJ	O	31	NMOD	3	angiogenic
31	challenge	challenge	I-NP	NN	O	29	PMOD	-1
32	by	by	B-PP	IN	O	12	VMOD	-1
33	s.c	s.c	B-NP	NN	O	32	PMOD	-1
34	.	.	O	.	O	11	P	-1

1	injection	injection	B-NP	NN	O	0	ROOT	0
2	with	with	B-PP	IN	O	1	NMOD	-1
3	an	an	B-NP	DT	O	6	NMOD	-1
4	angiogenic	angiogenic	I-NP	JJ	O	6	NMOD	3	angiogenic
5	gel	gel	I-NP	NN	O	6	NMOD	-1
6	substrate	substrate	I-NP	NN	O	2	PMOD	-1
7	(	(	O	(	O	11	DEP	-1
8	Matrigel	Matrigel	B-NP	NN	O	10	NMOD	-1
9	pellet	pellet	I-NP	NN	O	10	NMOD	-1
10	assay	assay	I-NP	NN	O	11	DEP	-1
11	)	)	O	)	O	6	NMOD	-1
12	.	.	O	.	O	1	P	-1

1	After	After	B-PP	IN	O	13	VMOD	-1
2	7	7	B-NP	CD	O	3	NMOD	-1
3	days	day	I-NP	NNS	O	1	PMOD	-1
4	,	,	O	,	O	13	P	-1
5	the	the	B-NP	DT	O	6	NMOD	-1
6	pellets	pellet	I-NP	NNS	O	13	SUB	-1
7	from	from	B-PP	IN	O	6	NMOD	-1
8	animals	animal	B-NP	NNS	O	12	NMOD	-1
9	fed	feed	B-VP	VBN	O	12	NMOD	0
10	the	the	B-NP	DT	O	12	NMOD	-1
11	control	control	I-NP	NN	O	12	NMOD	0
12	diet	diet	I-NP	NN	O	7	PMOD	-1
13	were	be	B-VP	VBD	O	0	ROOT	-1
14	infiltrated	infiltrate	I-VP	VBN	O	13	VC	-1
15	by	by	B-PP	IN	O	14	VMOD	-1
16	abundant	abundant	B-NP	JJ	O	18	NMOD	17	abundant
17	branching	branching	I-NP	NN	O	18	NMOD	2	branching
18	networks	network	I-NP	NNS	O	15	PMOD	-1
19	of	of	B-PP	IN	O	18	NMOD	-1
20	blood	blood	B-NP	NN	O	21	NMOD	-1
21	vessels	vessel	I-NP	NNS	O	19	PMOD	-1
22	with	with	B-PP	IN	O	21	NMOD	-1
23	patent	patent	B-NP	NN	B-cell_type	25	NMOD	-1
24	lumen-containing	lumen-containing	I-NP	JJ	I-cell_type	25	NMOD	-1
25	RBCs	RBC	I-NP	NNS	I-cell_type	22	PMOD	-1
26	.	.	O	.	O	13	P	-1

1	In	In	B-PP	IN	O	9	VMOD	-1
2	contrast	contrast	B-NP	NN	O	1	PMOD	-1
3	,	,	O	,	O	9	P	-1
4	pellets	pellet	B-NP	NNS	O	9	SUB	-1
5	from	from	B-PP	IN	O	4	NMOD	-1
6	the	the	B-NP	DT	O	8	NMOD	-1
7	CLA-fed	CLA-fed	I-NP	JJ	B-cell_line	8	NMOD	19	fed
8	animals	animal	I-NP	NNS	I-cell_line	5	PMOD	-1
9	contained	contain	B-VP	VBD	I-cell_line	0	ROOT	-1
10	fewer	few	B-NP	JJR	I-cell_line	12	NMOD	-1
11	infiltrating	infiltrate	I-NP	VBG	I-cell_line	12	NMOD	14	infiltrating
12	cells	cell	I-NP	NNS	I-cell_line	9	OBJ	-1
13	,	,	O	,	O	12	P	-1
14	which	which	B-NP	WDT	O	12	NMOD	-1
15	formed	form	B-VP	VBD	O	14	SBAR	2	formed
16	limited	limited	B-NP	JJ	O	19	NMOD	0
17	branching	branching	I-NP	JJ	O	19	NMOD	0
18	cellular	cellular	I-NP	JJ	O	19	NMOD	-1
19	networks	network	I-NP	NNS	O	15	OBJ	-1
20	,	,	O	,	O	9	P	-1
21	the	the	B-NP	DT	O	22	NMOD	-1
22	majority	majority	I-NP	NN	O	9	VMOD	-1
23	of	of	B-PP	IN	O	22	NMOD	-1
24	which	which	B-NP	WDT	O	23	PMOD	-1
25	had	have	B-VP	VBD	O	30	NMOD	-1
26	collapsed	collapse	I-VP	VBN	O	27	NMOD	6	collapsed
27	lumen	luman	B-NP	NNS	O	25	OBJ	-1
28	and	and	O	CC	O	30	NMOD	-1
29	no	no	B-NP	DT	O	30	NMOD	-1
30	RBCs	RBC	I-NP	NNS	B-cell_type	23	PMOD	-1
31	.	.	O	.	O	9	P	-1

1	Both	Both	B-NP	DT	O	2	NMOD	-1
2	levels	level	I-NP	NNS	O	6	SUB	-1
3	of	of	B-PP	IN	O	2	NMOD	-1
4	dietary	dietary	B-NP	JJ	O	5	NMOD	-1
5	CLA	CLA	I-NP	NN	O	3	PMOD	-1
6	showed	show	B-VP	VBD	O	0	ROOT	-1
7	similar	similar	B-NP	JJ	O	8	NMOD	-1
8	effects	effect	I-NP	NNS	O	6	OBJ	0
9	,	,	O	,	O	6	P	-1
10	with	with	B-PP	IN	O	6	VMOD	-1
11	the	the	B-NP	DT	O	12	NMOD	-1
12	number	number	I-NP	NN	O	10	PMOD	-1
13	of	of	B-PP	IN	O	12	NMOD	-1
14	RBC-containing	RBC-containing	B-NP	JJ	B-protein	15	NMOD	-1
15	vessels	vessel	I-NP	NNS	I-protein	13	PMOD	-1
16	per	per	B-PP	IN	O	12	NMOD	-1
17	20x	20x	B-NP	NN	O	18	NMOD	-1
18	field	field	I-NP	NN	O	16	PMOD	-1
19	decreased	decrease	B-VP	VBD	O	6	VMOD	0
20	to	to	B-PP	TO	O	19	VMOD	-1
21	a	a	B-NP	DT	O	22	NMOD	-1
22	third	third	I-NP	JJ	O	20	PMOD	-1
23	of	of	B-PP	IN	O	19	VMOD	-1
24	that	that	B-NP	DT	O	23	PMOD	-1
25	seen	see	B-VP	VBN	O	24	NMOD	-1
26	in	in	B-PP	IN	O	25	VMOD	-1
27	control	control	B-NP	NN	O	26	PMOD	0
28	.	.	O	.	O	6	P	-1

1	Dietary	Dietary	B-NP	JJ	O	2	NMOD	-1
2	CLA	CLA	I-NP	NN	O	3	SUB	-1
3	decreased	decrease	B-VP	VBD	O	0	ROOT	18	decreased
4	serum	serum	B-NP	NN	O	5	NMOD	-1
5	levels	level	I-NP	NNS	O	3	OBJ	-1
6	of	of	B-PP	IN	O	5	NMOD	-1
7	vascular	vascular	B-NP	JJ	B-protein	10	NMOD	-1
8	endothelial	endothelial	I-NP	JJ	I-protein	10	NMOD	-1
9	growth	growth	I-NP	NN	I-protein	10	NMOD	0
10	factor	factor	I-NP	NN	I-protein	18	NMOD	-1
11	(	(	O	(	O	13	DEP	-1
12	VEGF	VEGF	B-NP	NN	B-protein	13	DEP	-1
13	)	)	O	)	O	10	NMOD	-1
14	and	and	O	CC	O	18	NMOD	-1
15	whole	whole	B-NP	JJ	O	18	NMOD	-1
16	mammary	mammary	I-NP	JJ	O	18	NMOD	-1
17	gland	gland	I-NP	NN	O	18	NMOD	-1
18	levels	level	I-NP	NNS	O	6	PMOD	-1
19	of	of	B-PP	IN	O	18	NMOD	-1
20	VEGF	VEGF	B-NP	NN	B-protein	24	NMOD	-1
21	and	and	O	CC	O	24	NMOD	-1
22	its	its	B-NP	PRP$	O	24	NMOD	-1
23	receptor	receptor	I-NP	NN	O	24	NMOD	-1
24	Flk-1	Flk-1	I-NP	NN	B-protein	19	PMOD	-1
25	.	.	O	.	O	3	P	-1

1	Both	Both	B-NP	DT	O	10	NMOD	-1
2	cis-9	cis-9	I-NP	NN	B-DNA	10	NMOD	-1
3	,	,	I-NP	,	O	10	P	-1
4	trans-11	trans-11	I-NP	NN	B-protein	6	NMOD	-1
5	and	and	I-NP	CC	O	6	NMOD	-1
6	trans-10	trans-10	I-NP	NN	B-protein	10	NMOD	-1
7	,	,	O	,	O	10	P	-1
8	cis-12	cis-12	B-NP	JJ	B-protein	10	NMOD	-1
9	CLA	CLA	I-NP	NN	I-protein	10	NMOD	-1
10	isomers	isomer	I-NP	NNS	I-protein	11	SUB	-1
11	were	be	B-VP	VBD	O	0	ROOT	-1
12	effective	effective	B-ADJP	JJ	O	11	PRD	16	effective
13	in	in	B-PP	IN	O	12	AMOD	-1
14	inhibiting	inhibit	B-VP	VBG	O	13	PMOD	18	inhibiting
15	angiogenesis	angiogenesis	B-NP	NN	O	14	OBJ	3	angiogenesis
16	in	in	B-ADVP	FW	O	14	VMOD	-1
17	vitro	vitro	I-ADVP	FW	O	16	AMOD	-1
18	in	in	B-PP	IN	O	14	VMOD	-1
19	a	a	B-NP	DT	O	21	NMOD	-1
20	dose-dependent	dose-dependent	I-NP	JJ	O	21	NMOD	-1
21	fashion	fashion	I-NP	NN	O	18	PMOD	-1
22	.	.	O	.	O	11	P	-1

1	The	The	B-NP	DT	O	2	NMOD	-1
2	ability	ability	I-NP	NN	O	8	SUB	0
3	of	of	B-PP	IN	O	2	NMOD	-1
4	CLA	CLA	B-NP	NN	B-protein	3	PMOD	-1
5	to	to	B-VP	TO	O	6	VMOD	-1
6	inhibit	inhibit	I-VP	VB	O	2	NMOD	18	inhibit
7	angiogenesis	angiogenesis	B-NP	NN	O	6	OBJ	3	angiogenesis
8	may	may	B-VP	MD	O	0	ROOT	-1
9	contribute	contribute	I-VP	VB	O	8	VC	0
10	to	to	B-PP	TO	O	9	VMOD	-1
11	its	its	B-NP	PRP$	O	12	NMOD	-1
12	efficacy	efficacy	I-NP	NN	O	10	PMOD	0
13	as	as	B-PP	IN	O	9	VMOD	-1
14	a	a	B-NP	DT	O	16	NMOD	-1
15	chemopreventive	chemopreventive	I-NP	JJ	O	16	NMOD	-1
16	agent	agent	I-NP	NN	O	13	PMOD	-1
17	.	.	O	.	O	8	P	-1

